Berkeley, United States
Izote Biosciences, founded in 2022, is an innovative player in the Biotechnology and Life Sciences sectors, with its headquarters in the United States. The company is revolutionizing industrial fermentation by utilizing an alternative molecule that's 100,000x more soluble than oxygen, effectively eliminating the need for mechanical aeration equipment. This breakthrough enables the efficient and sustainable production of high-performance small molecules and proteins essential for the fragrance, pharmaceutical, and specialty chemical industries.
The company recently secured a $2.60M Pre Seed Round investment on 01 February 2024, attracting a diverse group of backers including Bee Partners, Nucleus Capital, Embark Ventures, FTW Ventures, RedStick Ventures, Courtyard Ventures, Climate Capital Bio, and EGB Capital. This funding underscores investor confidence in Izote Biosciences' potential to disrupt traditional fermentation methods and capitalize on substantial market demand.
